Using CHP staining, researchers observed active collagen turnover in grafts, indicating that the ECM was being actively remodelled.
Understanding ECM Remodelling in Full-Thickness Skin Grafts: Insights from Collagen Hybridising Peptide Staining
Advancing Intervertebral Disc Degeneration Assessment with Collagen Hybridising peptides: A Fast, Accurate Approach for Research and Clinical Applications
Collagen Hybridising Peptides (CHPs) selectively bind to damaged collagen, allowing precise visualisation and quantification of IVD in tissue samples.
Using Collagen Hybridising Peptides to Improve IPF Diagnosis and Imaging
This study uses collagen hybridising peptides (CHPs) to bind specifically to denatured collagen and detect fibrosis.
Collagen Hybridising Peptides Conjugated to Water-Soluble Copolymers for Targeting Intratibial Osteosarcoma
This paper explores conjugating CHPs to water-soluble N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for tumor targeting and drug delivery.
Human MHC Class II QuickSwitch™ Platform is used to Identify SARS-CoV-2 Virus Derived Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether that
How to Identify SARS-CoV-2 Virus Derived Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research), MBL International describes how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether
Find Human MHC Class I Dominant Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether
Comparing Theoretical Peptide-MHC Binding Affinity to Real Values produced by the QuickSwitch™ Platform
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether
How to screen SARS-CoV-2 peptides to facilitate T cell research
Whenever our immune system is faced with a challenge, be it a multicellular parasite, a bacteria, a virus, or even cancer, this threat is detected and sampled primarily by the protein sequence of the pathogen in question. Other aspects of